Innovative Eyewear Launches Four New Lucyd Lyte Smart Glasses with Enhanced Features
Prnewswire· 2024-11-25 21:30
New smart eyewear is the Company's first to use advanced TR90 plastic for improved adjustability and durability. MIAMI, Nov. 25, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. (NASDAQ: LUCY; LUCYW), the developer of ChatGPT-enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, announced today that it has officially launched the Lucyd Lyte 2024 Edition, bringing several improvements to the Company's core product line. Key improvements over previous models include improved adjustab ...
Dr Disrespect Will Lead Rumble Gaming & Join Rumble Premium
GlobeNewswire News Room· 2024-11-25 21:30
LONGBOAT KEY, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced that Dr Disrespect has joined Rumble and will be streaming his popular content on the platform. As part of an agreement that includes equity with milestones as a majority of its compensation, Dr Disrespect will provide exclusive content to Rumble Premium for his “Champions Club” community. Dr Disrespect will also lead Rumble Gaming, acting as an advisor and helpi ...
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
GlobeNewswire News Room· 2024-11-25 21:30
Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around mental health and comorbidity burdens of FOSNew pre-clinical data from the Company’s Nav1.1 program VANCOUVER, British Columbia and BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, t ...
Cellebrite Announces Participation in the UBS Global Technology and AI Conference
GlobeNewswire News Room· 2024-11-25 21:30
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) -- {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG} Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming UBS Global Technology and AI Conference. Relevant details include: Date:December 3, 2024Conference:UBS Global Technology and AI ConferencePresentation Time:4:55 p.m. ETFormatFireside ChatEvent URL:https://investo ...
Lytton Rancheria of California Leads Tribal Investment in Cadiz Groundwater Banking Project
Prnewswire· 2024-11-25 21:30
$50 million investment in Mojave Groundwater Bank would be the largest investment in water infrastructure off tribal-lands by Native American Tribes in U.S. historyLOS ANGELES and WINDSOR, Calif., Nov. 25, 2024 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI) (the "Company" or "Cadiz") announced today that the Company and the Lytton Rancheria of California ("Lytton") have signed a Letter of Intent for Lytton to invest up to $50 million in the Company's groundwater banking project in the Mojave Desert ("Mojave Gro ...
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
Prnewswire· 2024-11-25 21:30
ITASCA, Ill., Nov. 25, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), announces that Hupan Pharmaceutical (Hubei) Co., Ltd. ("Hupan Pharmaceutical"), a company recently acquired by Lakeside, has established partnership with Sinopharm Group Hubei Co., Ltd. ("Sinopharm Hubei"). Sinopharm Hubei is a ...
IceCure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance from Japan's Patent Office
Prnewswire· 2024-11-25 21:30
Invention facilitates treatment of larger tumors and is a significant leap forward in the field of cryoablationCAESAREA, Israel, Nov. 25, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a Notice of Allowance from the Japan Patent Office for its invention titled 'Cryogenic System with Mul ...
Sitka Drills 119.0 Metres of 1.05 g/t Gold, Including 37.9 Metres of 2.05 g/t Gold and 11.5 Metres of 4.32 g/t Gold in Initial Diamond Drilling at the Rhosgobel Intrusion at Its Flagship RC Gold Project in Yukon
Newsfile· 2024-11-25 21:30
Sitka Drills 119.0 Metres of 1.05 g/t Gold, Including 37.9 Metres of 2.05 g/t Gold and 11.5 Metres of 4.32 g/t Gold in Initial Diamond Drilling at the Rhosgobel Intrusion at Its Flagship RC Gold Project in YukonNovember 25, 2024 8:30 AM EST | Source: Sitka Gold Corp.DDRCRG-24-001 returned 164.8 metres of 0.82 g/t gold starting 9 metres from surface, including 119.0 metres of 1.05 g/t gold, 37.9 metres of 2.05 g/t gold and 11.5 metres of 4.32 g/t gold in the first ever diamond drill hole at Rho ...
MicroStrategy Stock Jumps as Bitcoin Trades Near $100K
Investopedia· 2024-11-25 21:25
核心观点 - MicroStrategy的股票在周一的盘前交易中大幅上涨,因为比特币价格首次接近10万美元大关 [1][2] 公司行动 - MicroStrategy自2020年8月以来一直在购买比特币,并在今年特别是特朗普在11月5日赢得选举后加大了购买力度 [3] - 截至11月17日,MicroStrategy持有331,200枚比特币,总购买价格约为165亿美元,平均购买价格约为49,874美元 [4] - MicroStrategy通过股票销售和可转换债券交易从资本市场筹集资金以购买比特币 [5] 市场表现 - MicroStrategy的股票在盘前交易中上涨了5.4%,今年累计涨幅超过500%,自11月5日特朗普赢得美国大选以来上涨了近90% [5] - 比特币价格在周五下午升至约99,800美元,周末交易中略有回落,周一上午交易价格略高于98,000美元 [2]
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
GlobeNewswire News Room· 2024-11-25 21:21
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, "MicroPort EP"), today announced regulatory approval of the Genesis RMN® System by China's National Medical Products Administration (NMPA). This approval is a significant milestone, making available the latest advances in minimally-invasive robotic technology to physicians and patients in China. MicroPort EP is initiating full commercial launch of Genesis through its exi ...